Oxidative damage and iron redistribution are associated with the pathogenesis and progression of multiple sclerosis (MS), but these aspects are not entirely replicated in rodent experimental autoimmune encephalomyelitis (EAE) models. Here, we report that oxidative burst and injury as well as redistribution of iron are hallmarks of the MS-like pathology in the EAE model in the common marmoset. Active lesions in the marmoset EAE brain display increased expression of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (p22phox, p47phox, and gp91phox) and inducible nitric oxide synthase immunoreactivity within lesions with active inflammation and demyelination, coinciding with enhanced expression of mitochondrial heat-shock protein 70 and superoxide dismutase 1 and 2. The EAE lesion-associated liberation of iron (due to loss of ironcontaining myelin) was associated with altered expression of the iron metabolic markers FtH1, lactoferrin, hephaestin, and ceruloplasmin. The enhanced expression of oxidative damage markers in inflammatory lesions indicates that the enhanced antioxidant enzyme expression could not counteract reactive oxygen and nitrogen species-induced cellular damage, as is also observed in MS brains. This study demonstrates that oxidative injury and aberrant iron distribution are prominent pathological hallmarks of marmoset EAE thus making this model suitable for therapeutic intervention studies aimed at reducing oxidative stress and associated iron dysmetabolism.
INTRODUCTION
The development of adequate treatments for progressive multiple sclerosis (MS) is hampered by the lack of an animal model that accurately reproduces pathological hallmarks of the human disease. Recent attention has focused on oxidative damage, mitochondrial dysfunction, and energy deficits as main causes of tissue damage and diminished re-myelination capacity during progression of MS (1, 2) . However, these features are insufficiently represented in rodent MS models, i.e. experimental autoimmune encephalomyelitis (EAE) (3) (4) (5) .
Tissue damage by reactive oxygen species (ROS) is an important cytotoxic effector mechanism of myeloid immune cells, such as macrophages. The cascade-like production of ROS starts with the activation of NADPH oxidase-2 (NOX2), which in active MS lesions is highly expressed by microglia and macrophages. The activation of NOX2 involves the translocation and assembly of cytosolic (p47phox and p67phox) with membrane-bound (gp91phox and p22phox) subunits into a multimeric complex expressed in membranes of phagolysosomes and the cell surface (6) (7) (8) . The function of NOX2 is transfer of electrons from NADPH to molecular oxygen, yielding superoxide anion (O À 2 ). The concomitant MS lesionrestricted expression of inducible nitric oxide synthase (iNOS) by astrocytes and macrophages produces nitric oxide that by reaction with superoxide gives the highly toxic peroxynitrite (4, 9, 10) .
The tissue response to increased ROS involves upregulation of various scavenger molecules (eg, superoxide dismutases [SOD] ) and chaperones (heat shock proteins [HSP]) to limit injury. Superoxide anion is neutralized by SOD, which converts the radical into the less toxic hydrogen peroxide, is neutralized by the antioxidant enzyme catalase and via the glutathione peroxidase pathway. Cytosolic SOD1 and mitochondrial SOD2 are ubiquitously expressed in the CNS and substantially increased in hypertrophic astrocytes and myelin-laden macrophages of the brain in MS patients (6, 9, 11) . Mitochondrial HSP 70 (mtHSP70) is chaperonin induced upon a variety of stressors, including oxidative stress (12) . ROS metabolites cause metabolic stress, peroxidation of lipids and proteins, and DNA alkylation, which are observed in MS lesions (13) . These features, together with mitochondrial defects and corresponding energy deficits, have been implicated as crucial pathological components of disease progression (14, 15) .
While some aspects of oxidative stress have been observed in rodent EAE models, the characteristic lesionrestricted redistribution of iron in MS is lacking (7) . The accumulation of iron in myelin and oligodendrocytes in the aging human brain can be detrimental when it is liberated upon demyelination because iron amplifies oxidative damage (16) . Iron liberation in MS is associated with lesionassociated changes in iron metabolic markers, such as ferritin heavy chain (FTH1), lactoferrin, hephaestin, and ceruloplasmin (17, 18) .
In recent years, the EAE model in the common marmoset (Callithrix jacchus) has emerged as a translationally relevant MS model that could bridge the gap between clinical and histopathological characteristics of murine EAE models and MS (19). CNS pathology in the marmoset EAE model typically involves both white matter (WM) and gray matter (GM) demyelination. Essentially all stages of WM lesion development ranging from early active lesions with myelin-laden macrophages to chronic gliotic lesions and the various types of GM lesions in MS have also been observed in marmoset EAE brain tissue (20) (21) (22) (23) .
In the current study, we examined whether the marmoset EAE model may represent an appropriate model to investigate processes involved in oxidative injury, such as oxidative burst and changes in iron metabolism. The extensive examination of marmoset EAE brain samples reported here demonstrates widespread oxidative tissue injury and aberrant iron distribution in the marmoset EAE brain, similarly to those observed in human MS brain lesions.
MATERIALS AND METHODS

Marmoset Tissue
Cryopreserved and formalin-fixed, paraffin-embedded tissues from previous marmoset EAE experiments performed at the Biomedical Primate Research Centre were used for this study (BPRC, Rijswijk, The Netherlands). These studies were reviewed and approved by the institutional ethics review committee. For a detailed description of EAE induction and monitoring of EAE course, see Jagessar et al (24) . Briefly, marmosets were immunized once (in the case of myelin or human recombinant myelin oligodendrocyte glycoprotein [rhMOG]) or every 28 days (inoculations with myelin oligodendrocyte glycoprotein peptide ) and monitored daily until the development of overt neurological disease (EAE score !2). An accumulative scoring system was implemented whereby a score 2 ¼ ataxia or optic disease; score 2.5 ¼ paresis of 1 or more limbs; and score 3 ¼ paralysis of 1 or more limbs. Ethical endpoints were in compliance with instructions of the ethics committee and are indicated for individual animals in Table 1 . Brain tissues were derived from EAE models induced with myelin emulsified in complete Freund's adjuvant (CFA), rhMOG emulsified in CFA (rhMOG/CFA), and MOG34-56/CFA or incomplete Freund's adjuvant (MOG34-56/IFA) (23, (25) (26) (27) (28) . Half brains were sectioned (coronal) at multiple locations during the embedding process; hence, different topographic regions of tissue could be analyzed at once on one slide. Marmosets (n ¼ 24) (Table 1 ) selected for this study were previously characterized for brain pathology, and featured prominent WM and GM pathology. The predilection sites of lesions in marmoset EAE models include, but are not limited to, corpus callosum and areas close to the ventricles; yet, demyelination is widespread. Representative lesions from coronal sections from mid-brain areas are shown.
Immunohistochemistry
For immunohistochemical staining of formalin-fixed paraffin embedded material, 5-mm sections were cut and deparaffinized using xylene (VWR, Radnor, PA) and rehydrated via graded ethanol. Endogenous peroxidase activity was blocked by incubating tissue in 0.03% H 2 O 2 (Sigma, St. Louis, MO), in methanol for 30 minutes. A pretreatment step was performed for antigen retrieval by steaming slides in ei- C. Biotin-labeled secondary antibodies (Jackson ImmunoResearch Laboratories, West Grove, PA) and avidin-labeled peroxidase were added prior to visualization with diaminobenzidine tetrachloride (DAB) (Sigma). A hemalaun counterstain was performed by 2-minute incubation with 1:10 diluted hemalaun (Merck Millipore; Billerica, MA). Finally, tissue was dehydrated with graded ethanol and xylene prior to mounting with malinol (Waldeck, Munster, Germany).
For double or triple fluorescent labeling, the above protocol was used, with minor deviations. Briefly, following overnight incubation at 4 C with primary antibodies diluted in Dako ready-to-use diluent (DAKO) or Tris-buffered saline (TBS) with 10% Fetal calf serum (FCS), slides were washed in Tris-buffered saline (TBS) and incubated for an additional 1 hour. For visualization, direct secondary antibodies against primary host species (mouse, goat, or sheep) conjugated to CY3 and CY5 (Jackson ImmunoResearch Laboratories) were used. For primary antibodies with rabbit host, a secondary biotin anti-rabbit antibody (Jackson ImmunoResearch Laboratories) was used prior to labeling with a Cy2-conjugated streptavidin (Jackson ImmunoResearch Laboratories). Cell nuclei were visualized using a commercially available Vectashield DAPI antifade mounting kit (Vector laboratories, Burlingame, CA).
Fluorescence detection was performed with a Leica systems microscope (DMI 600B; Leica Microsystems, Wetzlar, Germany) using a 63Â immersion oil lens.
To compare lesion content of p22phox and iNOS expression, images of active lesions (n ¼ 3 lesions/marmoset) were converted to 8 bit using ImageJ. A threshold was applied to images to eliminate non-specific staining, and the binary watershed feature was utilized to distinguish individual cells as clustering was often observed. Standard scale bars were used to calculate the area of the images and data is presented as the average (n ¼ 3) of positive cells/mm 2 in an active WM lesion.
Iron Staining
DAB-enhanced Turnbull staining of nonheme tissue (n ¼ 12 marmosets; Table 1 ) iron was performed on formalinfixed paraffin-embedded tissue sections as described previously (17, 29) . Briefly, 5-lm tissue sections were deparaffinized using xylene, rehydrated via graded ethanol, and treated with 10% ammonium sulfide (Merck Millipore; NY) for 1.5 hours and potassium-ferricyanide (Sigma) for 15 minutes. Endogenous peroxidase was blocked with 0.3% H 2 0 2 (Sigma) prior to amplification with 0.025% 3,3 0 -diaminobenzidine (Sigma). Hemalaun (Merck) counterstaining was performed as described above.
For quantification purposes, samples (n ¼ 12 marmosets) were stained simultaneously. Quantification was performed as described previously (17) on tissue from the MOG34-56 CFA (n ¼ 6) and IFA (n ¼ 6) groups, representing the most recent monkeys used in studies. Briefly, images 
Artwork and Statistics
Figures were compiled using Adobe InDesign CC 2015 (Adobe Systems, San Jose, CA), and in some cases, images were adjusted for brightness using Adobe Photoshop CC 2015 (Adobe Systems). Statistics (Mann-Whitney or linear regression correlation) was performed using GraphPad Prism 5.0 (GraphPad Software, Inc., La Jolla, CA).
RESULTS
NADPH and iNOS Oxidase Expression in White Matter Lesions
We observed that iNOS was strongly expressed in astrocytes and MRP14-positive microglia and in recently infiltrated macrophages in active WM lesions; iNOS expression was absent in NAWM (Fig. 1A-D , K-L). Active lesions were characterized by extensive macrophage/microglial expression of p22phox and gp91phox, whereas both NADPH oxidase subunits were only weakly expressed in microglia in NAWM (Fig.  1E-H, M) . In active WM lesions, p47phox was profoundly expressed in gp91phox-positive microglia/macrophages and virtually absent in the NAWM (Fig. 1I, J, N) .
Previous work showed that marmoset EAE can not only be induced with CFA as adjuvant but also by using IFA, an adjuvant lacking microbial components that relay danger signals to myeloid antigen-presenting cells. Hence, we quantified the number of cells expressing iNOS and p22phox in active WM lesions of animals immunized with MOG34-56 in either CFA or IFA. No differences in the number of cells expressing iNOS and p22phox were observed between the CFA and IFA groups ( Fig. 1O, P) .
iNOS and NADPH Oxidase Expression in Gray Matter Lesions
Expression of iNOS and p22phox was virtually absent in NAGM ( Fig. 2A-D) , but strikingly upregulated in active intracortical and leukocortical lesions. iNOS and p22phox expression was generally less abundant in intracortical lesions compared to WM lesions and leukocortical lesions (Fig. 2G -J, M-P). Overall, only a limited number of iNOS-and p22phox-immunoreactive cells were observed in inactive or late active subpial lesions (Fig. 2S-V) . In conclusion, our data show that iNOS and p22phox were highly upregulated in inflamed GM lesions in the marmoset EAE brain.
Enhanced Expression of Anti-Oxidant Enzymes Indicate Oxidative Stress
We investigated whether the enhanced expression of enzymes involved in free radical production in marmoset EAE lesions might coincide with induction of endogenous antioxidants, such as SOD1 and SOD2. Both cytosolic SOD1 and mitochondrial SOD2 were weakly expressed in glial cells in NAWM, but markedly upregulated in active lesions (Fig. 3A-F) . SOD2 expression was observed in astrocytes, macrophages/ microglia, axons, and neurons ( Fig. 3I-K) . Parenchymal SOD2 expression was markedly higher, at a basal level, in the NAGM (Fig. 2E) than NAWM (Fig. 3E) . Compared to NAGM and inactive subpial lesions, SOD2 expression was strongly upregulated in active leukocortical and intracortical lesions (Fig. 2K, Q, W) .
HSP Expression Confirms Stressed Mitochondria
The expression pattern of mtHSP70 closely mirrored that of SOD2 with a clear punctate staining pattern indicative of mitochondrial localization (Fig. 3G, H) . mtHSP70 immunoreactivity was markedly upregulated in active lesions compared to NAWM (Fig. 3G, H) . The expression of mtHSP70 was predominantly observed in oligodendrocytes and macrophages/microglia, but relatively less frequent in astrocytes (Fig. 3L, M) . Similar to SOD2, strong expression was observed in cells of neuronal morphology and in axons. Colocalization of SOD2 and mtHSP70 was frequently observed (Fig.  3N ) in macrophages/microglia or neurons. With respect to cortical regions of the brain, similar to SOD2, the NAGM exhibited a higher level of basal expression of mtHPS70 than the NAWM (Fig. 2F) . In the active leukocortical and intracortical lesion, mtHSP70 was upregulated (Fig. 2L, R) . Likewise, subpial lesion exhibited no changes with respect to mtHSP70 expression compared to similar areas of NAGM (Fig. 2X) .
Together, these data demonstrate that the inflamed marmoset EAE brain is under severe oxidative stress and that endogenous antioxidant factors (SOD1-2), and mtHSPs are markedly upregulated in active WM and cortical GM lesions.
Iron in the Marmoset Brain
Because iron can catalyze oxidative stress, we evaluated the presence of total non-heme iron in the marmoset brain by analyzing Turnbull staining of paraffin-embedded tissue sections. The marmoset EAE brain exhibited considerable accumulation of total nonheme iron in myelin and oligodendrocytes in NAWM. In demyelinated WM lesions, redistribution of iron was observed, probably caused by the loss of myelin (Fig.  4C-F) . A general pattern of iron loss increasing toward the center of the lesion was observed. This correlated to myelin loss and was accompanied by iron uptake in macrophages/ microglia and residual oligodendrocytes (Fig. 4C-F) .
Because iron accumulates in the human brain in an aging-associated manner (17), we analyzed the iron content in relation to age of the marmosets. There was a significant correlation between the age of the marmoset and iron accumulation (Fig. 4G) . Marmosets mature at 15 months of age and are typically used for EAE studies at 2 years of age. The age range of EAE marmosets (n ¼ 12) in which iron was quantified was from 21 to 59 months, representing young sexually mature monkeys in prime adult years. When data were further analyzed by grouping marmosets based upon age as very young 4 . Iron accumulates in the marmoset brain and is liberated upon demyelination. To determine tissue specific iron, Turnbull staining was performed on marmoset EAE brain tissue in an age range representing the lower and upper limits of age used in EAE studies. Shown is an overview image of PLP (A), MRP14 (B), and Turnbull (C) stain of a middle-aged (36 months, animal 20 in Table 1 ) marmoset with both NAWM and active demyelinating areas as determined by the presence of PLPþ macrophages (A, inset). Lesions are denoted by black arrows. (D-F) The images representative areas of NAWM, lesion edge and lesion center respectively. In areas of NAWM, strong accumulation of iron associated with myelin and oligodendrocytes was observed (D). Conversely, iron loads typically were highest in areas at the edge of demyelinating lesions (E) and typically lowest in lesion centers (F), corresponding to the loss of iron-containing myelin and oligodendrocytes. Iron content of the NAWM was plotted against age showing that accumulation of iron was age dependent, with older monkeys exhibiting strongest iron deposition (G, H). Image scale bars: 200 um (open square), 50 lm (closed circle).
( 25 months, mean ¼ 21.6) versus middle-aged monkeys (!25 months, mean ¼ 40.5), a clear age-associated iron accumulation was observed (Fig. 4G, H) . In conclusion, our data demonstrate age-associated iron accumulation and redistribution in marmoset EAE brain tissue similarly as observed in the adult human brain.
Iron Metabolic Markers Change With Demyelination
Next, we assessed the expression of various proteins involved in iron metabolism. Lactoferrin, an iron storage marker, was particularly expressed in astrocytes in the NAWM (Fig. 5A-C) . Lactoferrin expression was markedly upregulated in astrocytes and microglia/macrophages in periplaque WM (PPWM) and areas of active demyelination (Fig.  5D, K, L) . The iron binding marker ferritin (heavy chain, FTH1) was predominantly detected in macrophages/microglia and astrocytes throughout lesional areas (Fig. 5F, M, N) . In contrast, iron and ferritin-containing macrophages were not frequently observed in the NAWM (Fig. 5E ).
Hephaestin, a transmembrane copper-dependent ferroxidase (¼ Fe-oxido-reductase) molecule, exhibited a weak expression pattern in oligodendrocytes or occasionally in astrocytes in NAWM (Fig. 5G) . Active lesions showed an enhanced expression of hephaestin in in occasional residual oligodendrocytes and oligodendrocytes in PPWM (Fig. 5H) . In addition, hephaestin was expressed by astrocytes and macrophages (Fig. 5M, N) . Ceruloplasmin, a ferroxidase molecule, was present in NAWM in some microglia (Fig. 5I) . Ceruloplasmin immunoreactivity was markedly upregulated in PPWM and in active lesions and observed in macrophages, and occasionally in oligodendrocytes (Fig. 5J, Q, R) . Collectively, these data show that loss of myelin and oligodendrocytes in the marmoset EAE brain was associated with altered expression patterns of iron and iron metabolic markers and an uptake of iron in adjacent areas similarly as seen in MS brain lesions.
Extensive Oxidative Damage in Active Marmoset EAE Lesions
The lipid peroxidation markers 4-hydroxynonenal (4-HNE) and malondialdehyde (MDA2) were virtually absent in NAWM (Fig. 6A-C, G) . 4-HNE was markedly upregulated in astrocytes and macrophages/microglia in active WM lesions (Fig. 6D, K, L) . MDA2 was robustly expressed throughout active demyelinating lesion, particularly in macrophages (Fig.  6H, M, N) .
Extensive expression of 8-hydroxydeoxyguanosine (8-OHdG), a classical marker for oxidative damage to DNA, was observed in active WM lesions, but absent in NAWM (Fig.  6E, F) . Nitrotyrosine was weakly expressed in glial cells in the NAWM, whereas in active lesions and PPWM, nitrotyrosine immunoreactivity was strongly enhanced in astrocytes and macrophages (Fig. 6I, J) . In conclusion, these data show extensive accumulation of oxidative damage markers in inflamed marmoset EAE lesions.
DISCUSSION
Although rodent EAE models have supported the development of MS immunotherapies, they lack several clinical and pathological features of MS (4). Our current study demonstrates that the marmoset EAE model accurately replicates key aspects of MS pathology, including the occurrence of oxidative burst and associated oxidative stress and damage to essential biological macromolecules (20, 22, 30) . MS brain lesions, particularly active demyelinating lesions, show signs of ongoing severe oxidative stress as demonstrated by extensive accumulation of oxidized phospholipids and oxidized DNA, as well as enhanced expression of antioxidant factors (31) . Here, we performed an in-depth histological analysis of marmoset EAE brain tissues to study the expression of key proteins and markers involved in redox and iron metabolism and we determined the extent of oxidative damage. The central message of the current study is that the expression of markers indicative of oxidative stress and injury in active demyelinating marmoset EAE lesions show a similar expression and cellular distribution pattern as active demyelinating MS lesions: (1) ROSgenerating enzymes NADPH oxidase and iNOS are expressed in microglia/macrophages and are significantly upregulated throughout active lesions; (2) likewise, the antioxidant enzymes SOD1 and 2 decorate astrocytes and microglia/macrophages and are strongly upregulated in active lesions; (3) mitochondrial stress (mtHSP70) is markedly upregulated throughout inflamed WM and GM lesions; (4) the marmoset brain exhibits iron accumulation and displays specific alterations in iron and iron-associated metabolic markers; and (5) extensive accumulation of oxidative tissue injury markers was observed throughout active demyelinating lesions.
The extent of oxidative injury is fundamentally different in rodent EAE compared to MS tissues, with extensive oxidative injury only being observed in virus-induced models (4). Schuh et al (4) proposed several explanations for this discrepancy. NADPH oxidase and iNOS are very weakly expressed in most rodent EAE models, which might be explained by specificpathogen-free housing that limits peripheral innate and adaptive immune stimulation. Moreover, rodent EAE models lack accumulation of iron in myelin and oligodendrocytes. Unlike rodents, marmosets are conventionally housed and exposed to environmental pathogens and thus disease induction is juxtaposed on a pathogen educated marmoset immune system (19, 32). Interestingly, induction of oxidative stress did not differ per immunization protocol in marmoset EAE.
The lack of iron accumulation, together with reduced expression of enzymes involved in the production of ROS/RNS, within the rodent brain might explain the limited oxidative damage observed in rodent EAE models (4). Iron, while critical for the myelination process, is a recognized amplifier of oxidative damage (1) . The importance of neurodegenerationassociated iron dysregulation in the MS brain is suggested and evidence is emerging that iron liberation is involved in lesion expansion (33) . Although iron deficient mice appear to be resistant to EAE, and iron deposition has been noted in mouse EAE spinal cord tissue, overall iron deposition in the brain appears to be lacking in rodent species (5, 34) . Iron accumulation in older rodents, if present, appears to be limited to brain stem nuclei and is lacking in myelin tracts and oligodendrocytes showing active demyelination with uptake of PLP by macrophages (A, inset). In the NAWM (C), staining of 4-HNE was weakly expressed in some astrocytes or absent all together, but staining was markedly upregulated in active lesions (D). In the active lesion, strong 4-HNE expression (green, K, L), was observed in both astrocytes (red, K) and in macrophages (red, L). 8-0HdG was absent in NAWM (E), but could be observed in macrophages and astrocytes of the active lesion (F). MDA2 was fairly absent in NAWM (G), but markedly upregulated in the active lesion (H), with expression (green, M, N) observed in macrophages (MRP14 ¼ red, N), but not in astrocytes (red, M). Nitrotyrosine was weakly expressed in astrocytes in NAWM (I) and markedly upregulated in active lesion immune cells and astrocytes (J). Image scale bars: 500 lm (perpendicular line), 100 lm (closed square), 50 lm (closed circle) and 20 lm (arrows). Black arrow denotes WM lesions.
(4). Here, we show for the first time that iron accumulates in oligodendrocytes and myelin in the marmoset brain and that EAE results in altered expression of iron metabolic markers and iron content. Iron metabolism in non-human primates, including the marmoset, closely mirrors iron metabolism of man, but differs substantially from rodents, demonstrated by the different effects of iron chelator therapies (35, 36) . Metabolic processing of iron in primates, and the relatively quick time to physical maturation of marmosets, in relation to most non-human primates species, may explain the observation that iron accumulation was observed even in the youngest monkeys examined.
In conclusion, we demonstrate that oxidative stress and injury, pathological hallmarks of the MS brain, are accurately replicated in marmoset EAE and that iron accumulation and liberation may play a role in this process. Collectively, our data imply that the marmoset is a valuable preclinical MS animal model, in which new therapeutics aimed at reducing oxidative damage can be explored.
